Advertisement

Topics

Treatment for Psychogenic Disorders

2014-07-24 14:25:10 | BioPortfolio

Summary

This study will examine whether biofeedback treatment is effective in lessening or stopping movement symptoms in people with psychogenic movement disorder. People with this condition have increased or decreased movements that are not under their control and are not associated with any know problem with the nervous system. Biofeedback is a type of therapy that uses electronic instruments to monitor breathing and heart rate. This treatment has been effective in patients with anxiety and panic attacks.

People 18 years of age and older diagnosed with psychogenic movement disorder may be eligible for this study. Candidates are screened with a neurological history, physical examination and psychiatric evaluation.

Participants come to the NIH Clinical Center for nine 1-hour test sessions over an 8-week period for the following procedures:

Week 1 (two visits):

- Patients' movements are videotaped while they sit, stand and walk.

- Patients train on RESPeRATE device, a computerized musical biofeedback device to help slow theirs breathing rate. The device has three components: a computerized module, earphones, and a chest strap holding a breath sensor. The patients put the elastic strap around their chest, put on the earphones, and sit in a chair. The device monitors and analyzes their breathing to create a melody composed of two distinct tones - one for inhalation and one for exhalation. Patients are instructed to match their breathing to the tones, which gradually slow until they are breathing at a slower, therapeutic rate.

- Patients' breathing is monitored and analyzed for information on breathing pattern and rate.

- Patients complete questionnaires on level of relaxation before and after RESPeRATE training.

- Patients take the RESPeRATE device home to use for two 10-minute practice sessions per day. They complete relaxation questionnaires before and after each session.

Weeks 2-7:

- Patients' progress is monitored and reviewed from the previous week

- Patients' breathing is monitored and analyzed for information on breathing pattern and rate.

- Patients complete questionnaires on level of relaxation before and after RESPeRATE training.

- Patients are observed for 10 minutes while using the RESPeRATE device.

Week 8:

- Patients' progress is monitored and reviewed from the previous week

- Patients' breathing is monitored and analyzed for information on breathing pattern and rate.

- Patients complete questionnaires on level o...

Description

Objective:

To apply respiratory biofeedback to patients with Psychogenic Movement Disorders (PMD) with a goal of decreasing involuntary movements.

Study Population:

Patients diagnosed with "clinically definite" PMD based on the Fahn-Williams scale

Design: Open-label pilot study

Outcome measures:

- To evaluate a possible decrease or resolution in involuntary movements caused by PMD as measured by the Psychogenic Movement Disorder Scale. Videotaping will be performed pre- and post-treatment and the videos will be evaluated by movement disorder specialists who are blinded to the pre-treatment or post-treatment condition.

- To evaluate if respiratory biofeedback is an effective treatment for patients with PMD.

- To retrospectively evaluate the components of anxiety and depression with responders versus non-responders.

Study Design

N/A

Conditions

Movement Disorders

Location

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda
Maryland
United States
20892

Status

Completed

Source

National Institutes of Health Clinical Center (CC)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-24T14:25:10-0400

Clinical Trials [537 Associated Clinical Trials listed on BioPortfolio]

Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases

The purpose of this protocol is to identify families with inherited neurologic conditions, especially movement disorders, to evaluate affected and unaffected individuals clinically, and to...

Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders

Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary mo...

Assessment of Movement Skills in Autism Spectrum Disorder

this study is to explore the degree of impairement in movement skills in children with autistic spectrum disorders

Mirror Box Therapy as a Treatment Option for Functional Movement Disorders

The purpose of this study is to investigate the potential of using mirror box therapy as a therapeutic technique amongst patients with functional movement disorders. It is hypothesized tha...

Physiological Investigations of Movement Disorders

Background: - Previous studies have given researchers information on how the brain controls movement, how people learn to make fine, skilled movements, and why some people have mo...

PubMed Articles [6902 Associated PubMed Articles listed on BioPortfolio]

Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.

Abstracts of the 2nd Pan American Parkinson's Disease and Movement Disorders Congress.

The placebo response in Parkinson's disease and other movement disorders.

Post-Thalamic Stroke Movement Disorders: A Systematic Review.

After a stroke, movement disorders are rare manifestations mainly affecting the deep structures of the brain like the basal ganglia (44%) and thalamus (37%), although there have been case studies of m...

Crossing barriers: a multidisciplinary approach to children and adults with young-onset movement disorders.

Diagnosis of less common young-onset movement disorders is often challenging, requiring a broad spectrum of skills of clinicians regarding phenotyping, normal and abnormal development and the wide ran...

Medical and Biotech [MESH] Definitions

One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.

An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.

Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.

Bleeding into one or both CEREBRAL HEMISPHERES due to TRAUMA. Hemorrhage may involve any part of the CEREBRAL CORTEX and the BASAL GANGLIA. Depending on the severity of bleeding, clinical features may include SEIZURES; APHASIA; VISION DISORDERS; MOVEMENT DISORDERS; PARALYSIS; and COMA.

More From BioPortfolio on "Treatment for Psychogenic Disorders"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alternative Medicine
Complementary and alternative medicine (CAM) is the term for medical products and practices that are not part of standard care. Standard care is what medical doctors, doctors of osteopathy, and allied health professionals, such as nurses and physical the...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Searches Linking to this Trial